Quarterly report [Sections 13 or 15(d)]

Business Combination - Intangible Assets Acquired (Details)

v3.25.1
Business Combination - Intangible Assets Acquired (Details) - USD ($)
3 Months Ended 6 Months Ended
Mar. 31, 2025
Mar. 31, 2025
Indefinite-Lived Intangible Assets [Roll Forward]    
Impairment $ 0  
Goodwill [Roll Forward]    
Combination Date Fair Value 11,812,476  
Impairment 0  
Carrying Value 11,823,159 $ 11,823,159
Pharmagesic    
Indefinite-Lived Intangible Assets [Roll Forward]    
Combination Date Fair Value   69,500,000
Translation Adj   (3,730,051)
Carrying Value 65,769,949 65,769,949
Goodwill [Roll Forward]    
Combination Date Fair Value   12,493,727
Translation Adj   (670,568)
Carrying Value 11,823,159 11,823,159
Pharmagesic | Halneuron for Cancer Related Pain    
Indefinite-Lived Intangible Assets [Roll Forward]    
Combination Date Fair Value   59,900,000
Translation Adj   (3,214,822)
Carrying Value 56,685,178 56,685,178
Pharmagesic | Halneuron for Chemotherapy Induced Neuropathic Pain    
Indefinite-Lived Intangible Assets [Roll Forward]    
Combination Date Fair Value   9,600,000
Translation Adj   (515,229)
Carrying Value $ 9,084,771 $ 9,084,771